Wright collaborates with Tissue Engineering:
This article was originally published in Clinica
Executive Summary
US orthopaedics company Wright Medical Technology will set up a joint venture with Tissue Engineering to develop and distribute products for musculoskeletal applications. Tissue Engineering, based in Boston, is developing collagen-based scaffolds for ligament and tendon reconstruction, for cartilage regeneration and for use as a bone graft substitute. "These collagen scaffolds have the potential not only to repair bone and cartilage but also to re-grow ligaments and tendons," says Jack Parr, Wright's executive vice-president of R&D.